AbbVie Secures Imbruvica Exclusivity via Patent Thicket Until 2036
Town of Cheyenne WellsCity · CO- Approved
- Feb 1, 2024
- Renews
- Free account
The 30-second brief
AbbVie has amassed over 150 patents on Imbruvica with Johnson & Johnson, ensuring commercial exclusivity of the cancer drug until 2036 and delaying generics.
ABBVIE holds this contract with Town of Cheyenne Wells. Its other public contracts on record include work for Santa Ana Unified and Town of Antrim.
The renewal date is on record. A free account shows it, with the renewals for every Town of Cheyenne Wells contract.
Know when this contract comes back up.
See the renewal dateFree account · 30-second setup · No credit card
Contract details
- Document date
- February 1, 2024
- Term
- Exclusivity until 2036 for Imbruvica via multiple patent strategies
- Renews
- Free account
- Vendor
- ABBVIE
- Agency
- Town of Cheyenne Wells
- Source document
- accountableus_report_on_drug_patent_tactics.pdf (Report)
ABBVIE's other public contracts
More Town of Cheyenne Wells contracts
Questions about this contract
Who was awarded the government contract by Town of Cheyenne Wells?
ABBVIE was awarded this government contract by Town of Cheyenne Wells, as recorded on February 1, 2024.
What type of contract is this?
This is a government contract, documented as a report record.
Where was this contract approved?
This contract appears in accountableus_report_on_drug_patent_tactics.pdf (Report), dated February 1, 2024 from Town of Cheyenne Wells. Civic IQ extracts contract records directly from agency meeting documents and solicitations.
What other contracts does ABBVIE hold?
ABBVIE may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.
Show 1 more question
What is Town of Cheyenne Wells currently buying?
Explore Town of Cheyenne Wells's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.